Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates<sup>1</sup>

Shelby L. Dietrich(University of Southern California), Laurel A. Habel(Kaiser Permanente), Eva A. Operskalski(University of Southern California), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), M A Koerper(University of California, San Francisco), M W Hilgartner, James W. Mosley(University of Southern California), Jeanne M. Lusher(Science Factory), Charles H. Pegelow(University of Miami), Beatrice Lewis(Alta Bates Summit Medical Center), GF Gjerset(Bloodworks Northwest)
Vox Sanguinis
October 1, 1990
10.1111/j.1423-0410.1990.tb00846.x
Cited by 30

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587